TENDONOVA CORP

Profile

Company Names

TENDONOVA CORP

Addresses

75 FIFTH STREET NW, SUITE 2106, ATLANTA, GA 30308

50 SATELLITE BLVD., SUITE G, SUWANEE, GA 30024

50 SATELLITE BLVD., SUITE G, SUWANEE, GA 30024

3050 BUSINESS PARK DR., SUITE A2, NORCROSS, GA 30071

3050 BUSINESS PARK DR., SUITE A2, NORCROSS, GA 30071

1161 THE BY WAY NE, ATLANTA, GA 30306

Phone Numbers

(877) 203-0161
4705880420

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$3,847,599.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2024-06-26 
$270,000.00 
$400,000.00 
$130,000.00 
Debt 
6
2024-02-15 
$761,999.00 
$1,100,000.00 
$338,001.00 
Equity 
5
2023-11-01 
$250,000.00 
$500,000.00 
$250,000.00 
Debt 
4
2023-07-17 
$300,000.00 
$300,000.00 
$0.00 
Debt 
3
2022-07-29 
$440,000.00 
$700,000.00 
$260,000.00 
 
2
2021-09-22 
$446,300.00 
$2,000,000.00 
$1,553,700.00 
Equity 
1
2019-04-04 
$1,379,300.00 
$1,500,000.00 
$120,700.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
IAN 
 
CAMPBELL 
EXECUTIVE OFFICER, DIRECTOR
LUKA 
 
GRUJIC 
DIRECTOR
PETER 
 
HAALAND 
DIRECTOR
SHAWNA 
 
KHOURI 
DIRECTOR
LOUIS 
 
MALICE 
DIRECTOR
MARK 
 
SAMUELS 
EXECUTIVE OFFICER, DIRECTOR
JONATHAN 
 
SHAW 
EXECUTIVE OFFICER, DIRECTOR
ROY 
 
WALLEN 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-06-26 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-15 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-11-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-07-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-07-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-07-29 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-07-29 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2022-07-29 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-22 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-04-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-04-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-04-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-04-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-04-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-04-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-04-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-04-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#